4.5 Review

Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson's Disease: A Comparison of Direct and Indirect Systemic Stimulations

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 83, 期 4, 页码 1399-1413

出版社

IOS PRESS
DOI: 10.3233/JAD-210052

关键词

Animal models; behavior; mitochondrial activity; neuroprotection; neurotrophic factors

资金

  1. Michael J Fox Foundation
  2. Credit Agricole Sud Rhones Alpes
  3. Fondation Philanthropique Edmond J Safra
  4. France Parkinson
  5. French National Research Agency (ANR Carnot Institute)
  6. Tenix corp
  7. Salteri family

向作者/读者索取更多资源

Photobiomodulation has been shown to benefit animal models of Parkinson's disease by improving locomotive behavior and providing neuroprotection. It has also shown positive effects in people with Parkinson's disease, particularly in improving non-motor symptoms. The mechanisms behind these effects may involve direct stimulation of distressed neurons or indirect systemic protection through light influencing cells and molecules.
In recent times, photobiomodulation has been shown to be beneficial in animal models of Parkinson's disease, improving locomotive behavior and being neuroprotective. Early observations in people with Parkinson's disease have been positive also, with improvements in the non-motor symptoms of the disease being evident most consistently. Although the precise mechanisms behind these improvements are not clear, two have been proposed: direct stimulation, where light reaches and acts directly on the distressed neurons, and remote stimulation, where light influences cells and/or molecules that provide systemic protection, thereby acting indirectly on distressed neurons. In relation to Parkinson's disease, given that the major zone of pathology lies deep in the brain and that light from an extracranial or external photobiomodulation device would not reach these vulnerable regions, stimulating the distressed neurons directly would require intracranial delivery of light using a device implanted close to the vulnerable regions. For indirect systemic stimulation, photobiomodulation could be applied to either the head and scalp, using a transcranial helmet, or to a more remote body part (e.g., abdomen, leg). In this review, we discuss the evidence for both the direct and indirect neuroprotective effects of photobiomodulation in Parkinson's disease and propose that both types of treatment modality, when working together using both intracranial and extracranial devices, provide the best therapeutic option.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据